(Q58168509)

English

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

article by F. K. Knop et al published 16 January 2007 in Diabetologia

In more languages

Statements

scholarly article

0 references

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus (English)

0 references

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

object named as

S. Madsbad

3

0 references

Jens Juul Holst

4

object named as

J. J. Holst

0 references

author name string

F. K. Knop

1

0 references

T. Vilsbøll

2

0 references

T. Krarup

5

0 references

publication date

16 January 2007

0 references

0 references

50

0 references

4

0 references

797-805

0 references

https://scigraph.springernature.com/pub.10.1007/s00125-006-0566-z

0 references

Glucagon-related peptides in the human gastrointestinal mucosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hamster preproglucagon contains the sequence of glucagon and two related peptides.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon and the A cell: physiology and pathophysiology (second of two parts)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas*

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon and the A cell: physiology and pathophysiology (first two parts).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the physiology of GIP and GLP-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diminished Immunoreactive Gastric Inhibitory Polypeptide Response to a Meal in Newly Diagnosed Type I (Insulin-Dependent) Diabetics*

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired glucose tolerance: the irrepressible alpha-cell?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of alpha-cell function by the beta-cell during hypoglycemia in Wistar rats: the "switch-off" hypothesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The order of islet microvascular cellular perfusion is B----A----D in the perfused rat pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy intake in normal weight subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating glucagon after total pancreatectomy in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of methods for measurement of insulin secretion in humans in vivo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/17225124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-006-0566-Z

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58168509&oldid=1948994190"